EFFICACY OF IDARUBICIN IN THE TREATMENT OF ACUTE LEUKEMIA: A CLINICAL OBSERVATION
- VernacularTitle:去甲氧柔红霉素治疗急性白血病的临床疗效观察
- Author:
Xiaoying ZENG
;
Yu CHEN
;
Li ZHOU
- Publication Type:Journal Article
- Keywords:
Acute leukemia Idarubicin Chemotherapy
- From:
China Oncology
1998;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
PURPOSEObservation of clinical efficacy of idarubicin in the treatment of patients with both newly-diagnosed and relapsed/refractory acute leukemia. METHODS 34 patients of acute leukemia enrolled in this study are classified into 3 groups: newly-diagnosed, relapsed and refractory group. All patients are treated with combination chemotherapy composed of idarubicin and other agents. RESULTS The response rate for all patients is 70. 6% while the result in newly-diagnosed group is superior to both relapsed and refractory group (P
